# OnCo record paper-ebctcg-polychemotherapy-regimens-meta-analysis-lancet-2012 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-ebctcg-polychemotherapy-regimens-meta-analysis-lancet-2012/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-ebctcg-polychemotherapy-regimens-meta-analysis-lancet-2012" ;
  schema:name "Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials"@en ;
  schema:description "The Oxford overview of 123 trials and 100,000 women showing that anthracycline and taxane chemotherapy cuts breast cancer deaths by about a third, largely regardless of age, nodes, size, grade or hormone receptor status; it is the foundation triple-negative chemotherapy rests on."@en ;
  schema:url <https://onco.cc/key-papers/paper-ebctcg-polychemotherapy-regimens-meta-analysis-lancet-2012/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S0140-6736(11)61625-5>, <https://pubmed.ncbi.nlm.nih.gov/22152853/> ;
  onco:tag "tnbc-evidence" ;
  schema:sameAs <https://doi.org/10.1016/S0140-6736(11)61625-5> ;
  schema:datePublished "2012"^^xsd:gYear ;
  schema:author "Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Peto R, Davies C, et al." ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:drugs <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/paclitaxel/> ;
  onco:institutions <https://onco.cc/institutions/cruk/> ;
  onco:terms <https://onco.cc/terms/anthracycline/>, <https://onco.cc/terms/taxane/>, <https://onco.cc/terms/neoadjuvant-adjuvant/> ;
  onco:trials <https://onco.cc/trials/scarlet-s2212/> ;
  onco:people <https://onco.cc/people/richard-peto/> ;
  onco:journals <https://onco.cc/journals/lancet/> .